Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
Active, not recruiting · NCT04870203 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Phase 3 | 2026-03-17 | NCT04870203 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Biogen | 56 |
| Eli Lilly and Company | 370 |
| Ministry for Health and Solidarity, France | 5 |
| University Hospital, Bordeaux | 221 |
36 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.